Valuation metrics show that Bristol Myers Squibb Company may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The ...

Оценка 4,0 · StockInvest.us The Bristol-Myers Squibb stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term ...

Is Bristol-Myers Squibb stock a Buy, Sell or Hold? Bristol-Myers Squibb stock has received a consensus rating of hold. The average rating score is and is based ...

Bristol Myers Squibb Company (BMY) currently has an average brokerage recommendation (ABR) of 2.73 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated ...

Оценка 2,8 (8) The consensus among 8 Wall Street analysts covering (NYSE: BMY) stock is to Hold BMY stock. Out of 8 analysts, 0 (0%) are recommending BMY as a Strong Buy, 0 (0 ...

Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Оценка 4,0 (14) 9 analysts recommended to BUY the stock. 5 analysts recommended to SELL the stock.

Оценка 4,8 · MarketBeat There are currently 2 sell ratings, 13 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should " ...

28 июн. 2024 г. · Bristol Myers isn't a stock I'd buy right now. It may be a good option for dividend investors who want to take advantage of its 5.7%-yielding payout.